Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valentina Camera

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Therapeutic Advances in Neurological Disorders|April 10, 2026
Real-world effectiveness and safety of ofatumumab in multiple sclerosis: a longitudinal study integrating clinical, cognitive, and MRI outcomesStefano Ziccardi, Damiano Marastoni, Pietro Biasi, et al.
Diagnostics (Basel, Switzerland)|October 24, 2020
Kappa Index Versus CSF Oligoclonal Bands in Predicting Multiple Sclerosis and Infectious/Inflammatory CNS DisordersDiana Ferraro, Roberta Bedin, Patrizia Natali, et al.
Biomedicines|December 23, 2022
Immune Response after COVID-19 mRNA Vaccination in Multiple Sclerosis Patients Treated with DMTsValentina Mazziotti, Francesco Crescenzo, Agnese Tamanti, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 23, 2024
CSF Parvalbumin Levels at Multiple Sclerosis Diagnosis Predict Future Worse Cognition, Physical Disability, Fatigue, and Gray Matter DamageStefano Ziccardi, Agnese Tamanti, Claudia Ruggieri, et al.
Journal of Neurology|October 7, 2025
Predictors of relapse and disability in NMOSD, MOGAD, and double-seronegative demyelinating syndromes: an international multicenter retrospective cohort studyAbdulkadir Tunç, Emine Rabia Koc, Edgar Carnero Contentti, et al.
Multiple Sclerosis and Related Disorders|February 24, 2026
Cognition beyond relapses: cognitive progression independent of relapse activity reflects early smoldering neurodegeneration in multiple sclerosisStefano Ziccardi, Tom A Fuchs, Luigi Martinelli, et al.
Journal of Neurology|February 15, 2025
Multiple sclerosis diagnosis and its differential diagnosis in patients presenting with type four 'mirror pattern' CSF oligoclonal bandsDamiano Marastoni, Monica Sicchieri, Francesca B Pizzini, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 29, 2021
Early predictors of disability of paediatric-onset AQP4-IgG-seropositive neuromyelitis optica spectrum disordersValentina Camera, Silvia Messina, Kariem Tarek Elhadd, et al.
Journal of Neuroimmunology|May 23, 2020
Diagnostic features of initial demyelinating events associated with serum MOG-IgGRiccardo Orlandi, Sara Mariotto, Sergio Ferrari, et al.
Biomedicines|February 26, 2025
Identifying Biomarkers for Remyelination and Recovery in Multiple Sclerosis: A Measure of ProgressVito A G Ricigliano, Silvia Marenna, Serena Borrelli, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Therapeutic Advances in Neurological Disorders|April 10, 2026
Real-world effectiveness and safety of ofatumumab in multiple sclerosis: a longitudinal study integrating clinical, cognitive, and MRI outcomesStefano Ziccardi, Damiano Marastoni, Pietro Biasi, et al.
Diagnostics (Basel, Switzerland)|October 24, 2020
Kappa Index Versus CSF Oligoclonal Bands in Predicting Multiple Sclerosis and Infectious/Inflammatory CNS DisordersDiana Ferraro, Roberta Bedin, Patrizia Natali, et al.
Biomedicines|December 23, 2022
Immune Response after COVID-19 mRNA Vaccination in Multiple Sclerosis Patients Treated with DMTsValentina Mazziotti, Francesco Crescenzo, Agnese Tamanti, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 23, 2024
CSF Parvalbumin Levels at Multiple Sclerosis Diagnosis Predict Future Worse Cognition, Physical Disability, Fatigue, and Gray Matter DamageStefano Ziccardi, Agnese Tamanti, Claudia Ruggieri, et al.
Journal of Neurology|October 7, 2025
Predictors of relapse and disability in NMOSD, MOGAD, and double-seronegative demyelinating syndromes: an international multicenter retrospective cohort studyAbdulkadir Tunç, Emine Rabia Koc, Edgar Carnero Contentti, et al.
Multiple Sclerosis and Related Disorders|February 24, 2026
Cognition beyond relapses: cognitive progression independent of relapse activity reflects early smoldering neurodegeneration in multiple sclerosisStefano Ziccardi, Tom A Fuchs, Luigi Martinelli, et al.
Journal of Neurology|February 15, 2025
Multiple sclerosis diagnosis and its differential diagnosis in patients presenting with type four 'mirror pattern' CSF oligoclonal bandsDamiano Marastoni, Monica Sicchieri, Francesca B Pizzini, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 29, 2021
Early predictors of disability of paediatric-onset AQP4-IgG-seropositive neuromyelitis optica spectrum disordersValentina Camera, Silvia Messina, Kariem Tarek Elhadd, et al.
Journal of Neuroimmunology|May 23, 2020
Diagnostic features of initial demyelinating events associated with serum MOG-IgGRiccardo Orlandi, Sara Mariotto, Sergio Ferrari, et al.
Biomedicines|February 26, 2025
Identifying Biomarkers for Remyelination and Recovery in Multiple Sclerosis: A Measure of ProgressVito A G Ricigliano, Silvia Marenna, Serena Borrelli, et al.
Pageof 3